From: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals
Level of uncertainty
Decision
‘High’a (n = 19)
‘Low’b (n = 10)
Recommended
11
7
Optimised
4
1
Not recommended
2